相似文献
1
Guns N' viruses.
Microbes Infect. 2019 Apr-May;21(3-4):125-128. doi: 10.1016/j.micinf.2019.01.001. Epub 2019 Jan 23.
2
Ebola vaccines for mass immunisation in affected regions.
Lancet Infect Dis. 2022 Jan;22(1):8-10. doi: 10.1016/S1473-3099(21)00226-7. Epub 2021 Sep 13.
3
Vaccine trial launched to stop Ebola.
Science. 2018 May 18;360(6390):694-695. doi: 10.1126/science.360.6390.694.
4
Worries about Ebola outbreak grow, despite use of vaccine.
Science. 2018 Dec 14;362(6420):1225. doi: 10.1126/science.362.6420.1225.
5
Experimental drugs poised for use in Ebola outbreak.
Nature. 2018 May;557(7706):475-476. doi: 10.1038/d41586-018-05205-x.
6
'Make Ebola a thing of the past': first vaccine against deadly virus approved.
Nature. 2019 Nov;575(7783):425-426. doi: 10.1038/d41586-019-03490-8.
7
Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.
Clin Infect Dis. 2019 Jan 7;68(2):330-333. doi: 10.1093/cid/ciy527.
8
How Ebola-vaccine success could reshape clinical-trial policy.
Nature. 2015 Aug 6;524(7563):13-4. doi: 10.1038/524013a.
9
Ebola in eastern DRC.
Lancet Infect Dis. 2019 Oct;19(10):1049-1050. doi: 10.1016/S1473-3099(19)30422-0. Epub 2019 Aug 8.
10
New Ebola outbreak rings alarm bells early.
Science. 2017 May 26;356(6340):788-789. doi: 10.1126/science.356.6340.788.
引用本文的文献
1
Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay.
Int J Infect Dis. 2022 Apr;117:169-173. doi: 10.1016/j.ijid.2022.01.064. Epub 2022 Feb 1.
本文引用的文献
1
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication.
Cell. 2018 Dec 13;175(7):1917-1930.e13. doi: 10.1016/j.cell.2018.08.044.
2
A point-of-care diagnostic for differentiating Ebola from endemic febrile diseases.
Sci Transl Med. 2018 Dec 12;10(471). doi: 10.1126/scitranslmed.aat0944.
3
Identification of novel HLA-A11-restricted T-cell epitopes in the Ebola virus nucleoprotein.
Microbes Infect. 2019 Jan-Feb;21(1):56-62. doi: 10.1016/j.micinf.2018.04.005. Epub 2018 Oct 10.
4
Immunomonitoring of human responses to the rVSV-ZEBOV Ebola vaccine.
Curr Opin Virol. 2017 Apr;23:88-94. doi: 10.1016/j.coviro.2017.03.008. Epub 2017 Apr 28.
5
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).
Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23.
6
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
Nat Med. 2005 Jul;11(7):786-90. doi: 10.1038/nm1258. Epub 2005 Jun 5.
Zotero 插件
